Vivo Capital, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.20B
Q ending 2026-03-31
Prior quarter
$1.55B
Q ending 2025-12-31
Change
-22.2% QoQ · +59.3% YoY
Positions
46
reported holdings
Largest positions
All 46 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Erasca Inc | ERAS | Shares | $196.6M | 12.2M |
| Praxis Precision Medicines | PRAX | Shares | $109.2M | 339K |
| Terns Pharmaceuticals Inc | 430 | Shares | $70.4M | 1.3M |
| Trevi Therapeutics Inc | TRVI | Shares | $60.8M | 5.1M |
| Dbv Technologies Sa | DBVT | Shares | $55.7M | 2.7M |
| Compass Therapeutics Inc | CMPX | Shares | $50.5M | 9.5M |
| Tango Therapeutics Inc | TNGX | Shares | $45.1M | 2.2M |
| Sab Biotherapeutics Inc | SABS | Shares | $43.7M | 11.4M |
| Corvus Pharmaceuticals Holdings | CRVS | Shares | $41.0M | 2.8M |
| Bright Minds Biosciences Inc | DRUG | Shares | $40.7M | 557K |
| Sinovac Biotech Ltd. | Shares | $38.2M | 5.9M | |
| Dianthus Therapeutics Inc | DNTH | Shares | $29.7M | 354K |
| Dyne Therapeutics Inc | DYN | Shares | $28.2M | 1.6M |
| Abivax Sa - Adr | ABVX | Shares | $26.7M | 240K |
| Minerva Neurosciences Inc | NERV | Shares | $26.0M | 4.3M |
| Aclaris Therapeutics, Inc. | ACRS | Shares | $25.0M | 6.7M |
| Oric Pharmaceuticals Inc | ORIC | Shares | $23.4M | 1.8M |
| Alto Neuroscience Inc | ANRO | Shares | $23.3M | 1.0M |
| Sensei Biotherapeutics Inc | FTH | Shares | $22.8M | 722K |
| Arrivent Biopharma Inc | AVBP | Shares | $20.4M | 886K |
| Lb Pharmaceuticals Inc | LBRX | Shares | $19.7M | 800K |
| Veradermics Inc | MANE | Shares | $18.9M | 300K |
| Camp4 Therapeutics Inc | CAMP | Shares | $18.7M | 4.2M |
| Moonlake Immunotherapeutics | MLTX | Shares | $18.6M | 1.0M |
| Design Therapeutics Inc | DSGN | Shares | $17.2M | 1.6M |
| Cogent Biosciences Inc | COGT | Shares | $16.3M | 422K |
| Geron Corp | GERN | Shares | $12.9M | 8.7M |
| Unicycive Therapeutics | UNCY | Shares | $11.8M | 1.8M |
| An2 Therapeutics Inc | ANTX | Shares | $10.8M | 3.2M |
| Olema Pharmaceuticals Inc | OLMA | Shares | $10.0M | 672K |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $9.9M | 295K |
| Eupraxia Pharmaceuticals Inc | EPRX | Shares | $9.8M | 1.4M |
| Onkure Therapeutics Inc | OKUR | Shares | $8.0M | 1.9M |
| Surrozen Inc | SRZN | Shares | $7.6M | 260K |
| Alx Oncology Holdings Inc | ALXO | Shares | $6.4M | 3.2M |
| Monopar Therapeutics Inc | MNPR | Shares | $5.0M | 91K |
| Satellos Bioscience Inc | MSLE | Shares | $4.6M | 814K |
| Pepgen Inc | PEPG | Shares | $4.1M | 2.3M |
| Sera Prognostics Inc | SERA | Shares | $3.4M | 1.7M |
| Tenax Therapeutics Inc | TENX | Shares | $3.3M | 208K |
| Viridian Therapeutics Inc | VRDN | Shares | $3.3M | 166K |
| Instil Bio Inc | TIL | Shares | $2.4M | 293K |
| Pasithea Therapeutics Corp | KTTA | Shares | $1.6M | 2.1M |
| Compass Pathway Plc | CMPS | Shares | $1.1M | 200K |
| Bolt Therapeutics Inc | BOLT | Shares | $293K | 72K |
| Precision Biosciences Inc | DTIL | Shares | $26K | 5K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.